Unable to view this mail? Please click here to view in browser
Vertical_Talk Healthcare GlaxoSmithKline Plant Bengaluru
Drug-Polymer Solid Dispersions
Takeda-CiRA Collaboration
US Generic Enoxaparin
e-Newsletter www.pharmafocusasia.com | Archives | Advertise

News

Maryland-based Sucampo Pharma Makes $276 million...

Germany-based IDT Biologika acquires Autogenous Vaccine Manufacturer...

Alvogen to acquire Product Portfolio from Pfizer for the...
Press Releases

Syndax Enters Clinical Trial Collaboration in Cancer...

Merus enters into 72.8 million euro series C financing led by...

Immatics and MD Anderson announce launch of Immatics US...

Events

Sep 2nd - Sep 3rd
PharmaLytica

Sep 3rd - Sep 5th
Biotech China 2015

Sep 7th - Sep 10th
2nd Annual Data Integrity & Quality Matrics
Interviews  
Takeda Pharmaceutical Company Limited
Andrew Plump, M.D., Ph.D
Chief Medical & Scientific Officer
Scientific progress depends upon collaboration iPS cell technology is at the forefront of pharmaceutical innovation and Takeda strives to bring innovative treatments to patients Both Takeda and CiRA have the common goal of providing patients and healthcare professionals with innovative new...
Articles  
Enabling the Delivery of Poorly Soluble Drugs via Drug-Polymer Solid Dispersions
Amorphous Solid Dispersions (ASDs) are a preferred technology for improving solubility and bioavailability of poorly soluble drugs. Spray-drying and hot-melt extrusion are the most common ASD production methods, and polymer-drug interactions play a role in each.There are several factors to consider...
Projects  
GlaxoSmithKline Pharmaceuticals plans to set up pharma plant in Bengaluru, India
GlaxoSmithKline Pharmaceuticals (GSK Pharma) will invest Rs 1000 crore for greenfield manufacturing facility at Vemgal near Bengaluru, India.The greenfield facility, which will have an installed capacity of over 9 billion tablets and capsules per year, is expected to be operational by 2017...
Research Insights  
Analytical and statistical comparability of generic enoxaparins from the US market with the originator product
Abstract Lowmolecularweight heparins LMWHs are complex anticoagulant drugs made from heparin porcine mucosa starting material Enoxaparin sodium manufactured by Sanofi is one of the most widely prescribed LMWHs and has been used since 1993 in the USA. In 2010. US Food and Drug...
Current Issue
Current Issue
Editorial Calender
Media Pack
Books
e-Magazine| Subscribe | Unsubscribe Pharma Focus Asia
www.pharmafocusasia.com – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555